Compare Kenvue Inc. Common Stock (KVUE) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Relay Therapeutics Inc. Common Stock trades at $18.28 (market cap $3.82B). The key difference: Kenvue Inc. Common Stock is far larger — about 8.9× Relay Therapeutics Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| KVUE | RLAY | |
|---|---|---|
Market Cap | $34.06B | $3.82B |
Volume | 23,267,228 | 4,332,079 |
Sector | Consumer Staples | Health |
52-Week High | $19.83 | $20.75 |
52-Week Low | $14.11 | $6.03 |
Enterprise Value | $41.56B | $2.93B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
